Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Shareholder's Equity

v3.24.1.1.u2
Condensed Consolidated Statements of Changes in Shareholder's Equity - USD ($)
$ in Thousands
Common Shares
Additional Paid-in Capital
Warrants
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Non-Controlling Interest
Total
Balance at beginning of period at Dec. 31, 2022 $ 858,143 $ 225,127 $ 796 $ 988 $ (963,703) $ 166 $ 121,517
Balance at beginning of period (in shares) at Dec. 31, 2022 377,515,391            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Share-based compensation   31         31
Warrants expired   67 (67)        
Issuance and vesting of restricted share units $ 209           209
Issuance and vesting of restricted share units (in shares) 370,744            
Shares reserved for contingent consideration $ 53           53
Warrants issued as part of debt modification     5,106       5,106
Comprehensive (loss) income for the period       (2) (4,875) 9 (4,868)
Balance at end of the period at Mar. 31, 2023 $ 858,405 225,225 5,835 986 (968,578) $ 175 122,048
Balance at end of period (in shares) at Mar. 31, 2023 377,886,135            
Balance at beginning of period at Dec. 31, 2023 $ 856,422 225,250 5,835 973 (1,026,087)   62,393
Balance at beginning of period (in shares) at Dec. 31, 2023 384,833,546            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Share-based compensation   17         17
Issuance and vesting of restricted share units $ 90           90
Issuance and vesting of restricted share units (in shares) 2,613,463            
Comprehensive (loss) income for the period       (7) (9,651)   (9,658)
Balance at end of the period at Mar. 31, 2024 $ 856,512 $ 225,267 $ 5,835 $ 966 $ (1,035,738)   $ 52,842
Balance at end of period (in shares) at Mar. 31, 2024 387,447,009